OR WAIT null SECS
May 02, 2016
Safe handling of HPAPIs requires determining exposure potential and selecting appro-priate containment strategies.
Bioprocess operations-from cell line selection to final filtration-can influence the consistency and purity of biologic drug substances.
April 18, 2016
Shire announces plans to build a flexible biopharmaceutical manufacturing facility in County Meath, Ireland.
April 02, 2016
Manufacturing highly toxic compounds in a biopharmaceutical environment tests equipment and systems.
A global API marketplace increases the burden of supply chain monitoring for drug companies.
April 01, 2016
Unsafe material may remain in the US supply chain, according to a March 29th letter to FDA Commissioner Califf
March 29, 2016
Novo Nordisk broke ground on a facility in Clayton, NC, to manufacture APIs for GLP-1 and insulin medicines.
March 24, 2016
Collaboration will provide for unified development and manufacture of antibody drug conjugates.
March 15, 2016
The authors present analysis of the state of control of intermediate identity and quality, based on analysis of recently submitted DMFs.
March 02, 2016
Asking the right questions is crucial to establishing a biopharmaceutical facility design.